Compare Enzyme (MLN) vs Anoma (XAN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enzyme vs Anoma — how do they compare? Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume), while Anoma trades at Rp193.23 (market cap Rp484,4M, Rp70,3M 24h volume). The key difference: Anoma is far larger — about 3.6× Enzyme's market cap, and Anoma's supply is capped (2,5B / 10B XAN (25%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Enzyme for 29 Days and Anoma for 4 Days on average.
| MLN | XAN | |
|---|---|---|
Market Cap | Rp134,13M | Rp484,4M |
Volume (24h) | Rp104,56M | Rp70,3M |
Circulating Supply | 3,3M MLN | 2,5B / 10B XAN (25%) |
Typical Hold Time | 29 Days | 4 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Enzyme (MLN) shows limited market activity with a modest market cap of Rp134,13M and circulating supply of 3,3jt tokens. The asset demonstrates relatively low volatility with an average hold time of 29 days, suggesting stable holder behavior. Trading volumes appear subdued across exchanges, indicating limited speculative interest. No significant protocol upgrades or ecosystem developments have been reported recently, though the project continues to operate its decentralized asset management platform.
Overall outlook remains cautious due to limited liquidity and trading activity. Key opportunities include potential ecosystem growth in decentralized finance asset management, while major risks include low market depth, regulatory uncertainty for DeFi protocols, and competition from larger DeFi platforms. The token's utility within its native protocol remains its primary value driver.
Anoma (XAN) currently trades at Rp202.22 with a market cap of Rp507.15M, showing bearish technical signals from moving averages while oscillators remain neutral. The token has 25% circulating supply with 4-day average hold time. Current price sits near the pivot point of Rp197, with immediate resistance at Rp204 and support at Rp191. No major protocol updates or ecosystem developments were identified in recent analysis.
Overall outlook remains cautious with bearish technical momentum outweighing neutral oscillators. Key opportunity lies in potential bounce from support levels, while major risks include low liquidity, limited exchange presence, and typical crypto volatility. Investors should monitor for any ecosystem developments that could drive adoption.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Enzyme
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →About Anoma
Anoma is a decentralized operating system that enables developers to build a single app that can run on any blockchain. Its intent-centric architecture simplifies infrastructure complexity, improving development efficiency and user experience. Anoma supports a unified app layer that brings Web3 app functionality closer to Web2 usability.
Read more on XAN →
